These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 16127466)

  • 1. Targeted complement inhibition by C3d recognition ameliorates tissue injury without apparent increase in susceptibility to infection.
    Atkinson C; Song H; Lu B; Qiao F; Burns TA; Holers VM; Tsokos GC; Tomlinson S
    J Clin Invest; 2005 Sep; 115(9):2444-53. PubMed ID: 16127466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A complement C3 inhibitor specifically targeted to sites of complement activation effectively ameliorates collagen-induced arthritis in DBA/1J mice.
    Song H; Qiao F; Atkinson C; Holers VM; Tomlinson S
    J Immunol; 2007 Dec; 179(11):7860-7. PubMed ID: 18025232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel targeted inhibitor of the alternative pathway of complement and its therapeutic application in ischemia/reperfusion injury.
    Huang Y; Qiao F; Atkinson C; Holers VM; Tomlinson S
    J Immunol; 2008 Dec; 181(11):8068-76. PubMed ID: 19017999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted Complement Inhibition Protects Vascularized Composite Allografts From Acute Graft Injury and Prolongs Graft Survival When Combined With Subtherapeutic Cyclosporine A Therapy.
    Zhu P; Bailey SR; Lei B; Paulos CM; Atkinson C; Tomlinson S
    Transplantation; 2017 Apr; 101(4):e75-e85. PubMed ID: 28045880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new treatment for neurogenic inflammation caused by EV71 with CR2-targeted complement inhibitor.
    Qiu S; Liu N; Jia L; Yang G; Su W; Li J; Song L; Yang C; Wang J; Zhang C; Wang Z; Qiao F; Tomlinson S; Atkinson C; Sun Y; Huang L; Song H; Wang Y; Li Z
    Virol J; 2012 Nov; 9():285. PubMed ID: 23173749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement inhibitor, complement receptor 1-related gene/protein y-Ig attenuates intestinal damage after the onset of mesenteric ischemia/reperfusion injury in mice.
    Rehrig S; Fleming SD; Anderson J; Guthridge JM; Rakstang J; McQueen CE; Holers VM; Tsokos GC; Shea-Donohue T
    J Immunol; 2001 Nov; 167(10):5921-7. PubMed ID: 11698469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of antibody-induced glomerulonephritis with Crry-Ig, a soluble murine complement inhibitor.
    Quigg RJ; Kozono Y; Berthiaume D; Lim A; Salant DJ; Weinfeld A; Griffin P; Kremmer E; Holers VM
    J Immunol; 1998 May; 160(9):4553-60. PubMed ID: 9574562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The human complement receptor type 2 (CR2)/CR1 fusion protein TT32, a novel targeted inhibitor of the classical and alternative pathway C3 convertases, prevents arthritis in active immunization and passive transfer mouse models.
    Fridkis-Hareli M; Storek M; Or E; Altman R; Katti S; Sun F; Peng T; Hunter J; Johnson K; Wang Y; Lundberg AS; Mehta G; Banda NK; Michael Holers V
    Mol Immunol; 2019 Jan; 105():150-164. PubMed ID: 30513451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new therapeutic strategy for lung tissue injury induced by influenza with CR2 targeting complement inhibitor.
    Zhang C; Xu Y; Jia L; Yang Y; Wang Y; Sun Y; Huang L; Qiao F; Tomlinson S; Liu X; Zhou Y; Song H
    Virol J; 2010 Feb; 7():30. PubMed ID: 20144216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose targeted complement inhibition protects against renal disease and other manifestations of autoimmune disease in MRL/lpr mice.
    Atkinson C; Qiao F; Song H; Gilkeson GS; Tomlinson S
    J Immunol; 2008 Jan; 180(2):1231-8. PubMed ID: 18178863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A role for complement in the enhanced susceptibility of steatotic livers to ischemia and reperfusion injury.
    He S; Atkinson C; Evans Z; Ellett JD; Southwood M; Elvington A; Chavin KD; Tomlinson S
    J Immunol; 2009 Oct; 183(7):4764-72. PubMed ID: 19752222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An allelic variant of Crry in the murine Sle1c lupus susceptibility interval is not impaired in its ability to regulate complement activation.
    Tchepeleva SN; Thurman JM; Ruff K; Perkins SJ; Morel L; Boackle SA
    J Immunol; 2010 Aug; 185(4):2331-9. PubMed ID: 20660348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement plays an important role in spinal cord injury and represents a therapeutic target for improving recovery following trauma.
    Qiao F; Atkinson C; Song H; Pannu R; Singh I; Tomlinson S
    Am J Pathol; 2006 Sep; 169(3):1039-47. PubMed ID: 16936276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of post-stroke degenerative and regenerative processes and subacute protection by site-targeted inhibition of the alternative pathway of complement.
    Alawieh A; Elvington A; Zhu H; Yu J; Kindy MS; Atkinson C; Tomlinson S
    J Neuroinflammation; 2015 Dec; 12():247. PubMed ID: 26714866
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Lei B; Sleiman MM; Cheng Q; Tu Z; Zhu P; Goddard M; Martins PN; Langerude L; Nadig S; Tomlinson S; Atkinson C
    Front Immunol; 2021; 12():630581. PubMed ID: 34394069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting pathogenic postischemic self-recognition by natural IgM to protect against posttransplantation cardiac reperfusion injury.
    Atkinson C; Qiao F; Yang X; Zhu P; Reaves N; Kulik L; Goddard M; Holers VM; Tomlinson S
    Circulation; 2015 Mar; 131(13):1171-80. PubMed ID: 25825397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement-dependent P-selectin expression and injury following ischemic stroke.
    Atkinson C; Zhu H; Qiao F; Varela JC; Yu J; Song H; Kindy MS; Tomlinson S
    J Immunol; 2006 Nov; 177(10):7266-74. PubMed ID: 17082645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue-specific deletion of Crry from mouse proximal tubular epithelial cells increases susceptibility to renal ischemia-reperfusion injury.
    Miao J; Lesher AM; Miwa T; Sato S; Gullipalli D; Song WC
    Kidney Int; 2014 Oct; 86(4):726-37. PubMed ID: 24850152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A minimum CR2 binding domain of C3d enhances immunity following vaccination.
    Bower JF; Ross TM
    Adv Exp Med Biol; 2006; 586():249-64. PubMed ID: 16893077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of antibody-dependent mechanisms of tumor cell lysis by a targeted activator of complement.
    Imai M; Ohta R; Varela JC; Song H; Tomlinson S
    Cancer Res; 2007 Oct; 67(19):9535-41. PubMed ID: 17909064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.